Lam Research (NASDAQ:LRCX) Stock Price Down 8.8% - Should You Sell?

Key Points

• Stock slid 8.8% intraday to about $209.78 on Wednesday from a $230.10 close, with volume up ~36% (≈19.5M shares), signaling a sharp pullback/rotation despite recent strength.
• Analysts remain bullish: several firms raised price targets (Argus to $280, B. Riley to $310) and the consensus rating is a "Moderate Buy" with a $243.32 average target, reflecting continued upside expectations.
• Fundamentals are strong — Lam beat estimates with $1.27 EPS vs $1.17 expected and $5.34B revenue (+22% YoY) and set Q3 2026 EPS guidance of 1.250–1.450, while management and board changes aim to boost execution for AI-driven demand.

Lam Research Corporation (NASDAQ:LRCX - Get Free Report) shares were down 8.8% on Wednesday . The stock traded as low as $205.11 and last traded at $209.78. Approximately 19,528,766 shares changed hands during mid-day trading, an increase of 36% from the average daily volume of 14,349,592 shares. The stock had previously closed at $230.10.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Argus raised its price target on LRCX to $280 (from $175), implying sizable upside and signaling renewed analyst conviction in Lam’s growth trajectory. Argus price target raise
• Positive Sentiment: B. Riley boosted its price target to $310 and reiterated a Buy rating, adding institutional support for upside expectations. B. Riley price target lift
• Positive Sentiment: Market coverage noted LRCX trading up and hitting a new 52‑week high following analyst upgrades, reflecting strong near-term sentiment even as volatility appears. Trading up after analyst upgrade
• Positive Sentiment: Management changes and a new board addition (Cadence CEO Dr. Anirudh Devgan) are intended to increase execution velocity for the AI era — positive for strategic oversight and AI-related demand positioning. Leadership transitions Board appointment
• Positive Sentiment: Analyst-oriented coverage (Zacks) highlights Lam’s earnings momentum and growth attributes, reinforcing buy-side narratives around accelerating revenue and AI-driven wafer fab equipment demand. Zacks growth thesis Zacks earnings momentum
• Neutral Sentiment: Lam expanded R&D collaboration with CEA‑Leti — a constructive long-term technical partnership but with limited immediate market impact. CEA-Leti collaboration
• Neutral Sentiment: Industry context: a MarketBeat piece on KLA highlights differing WFE growth messaging across peers — useful context for interpreting Lam’s guidance but not a direct negative to Lam. KLA industry context
• Negative Sentiment: MarketWatch flagged short-term underperformance versus some competitors despite daily gains, suggesting rotation/profit-taking that likely contributed to today’s pullback. MarketWatch underperformance

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on LRCX shares. Evercore ISI set a $275.00 target price on shares of Lam Research in a research report on Thursday, January 29th. KeyCorp reaffirmed a "sector weight" rating on shares of Lam Research in a report on Thursday, January 29th. Wells Fargo & Company lifted their price objective on shares of Lam Research from $250.00 to $290.00 and gave the company an "overweight" rating in a research note on Thursday, January 29th. Summit Insights upgraded Lam Research from a "hold" rating to a "buy" rating in a research report on Thursday, January 29th. Finally, Wall Street Zen lowered Lam Research from a "buy" rating to a "hold" rating in a report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $243.32.

Lam Research Trading Down 8.8%

The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The stock has a market cap of $261.97 billion, a P/E ratio of 42.99, a PEG ratio of 2.59 and a beta of 1.78. The firm's fifty day moving average price is $190.60 and its two-hundred day moving average price is $148.53.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion during the quarter, compared to analysts' expectations of $5.23 billion. During the same period in the previous year, the business earned $0.91 earnings per share. The firm's revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Insiders Place Their Bets

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.31% of the stock is owned by corporate insiders.

Institutional Trading of Lam Research

A number of hedge funds have recently made changes to their positions in the stock. Catalyst Financial Partners LLC raised its position in Lam Research by 21.8% during the fourth quarter. Catalyst Financial Partners LLC now owns 5,600 shares of the semiconductor company's stock valued at $959,000 after purchasing an additional 1,004 shares in the last quarter. Strategic Family Wealth Counselors L.L.C. purchased a new position in shares of Lam Research during the 4th quarter valued at about $660,000. Independent Advisor Alliance raised its holdings in shares of Lam Research by 4.9% during the 4th quarter. Independent Advisor Alliance now owns 43,542 shares of the semiconductor company's stock valued at $7,454,000 after buying an additional 2,018 shares in the last quarter. Legacy Financial Advisors Inc. lifted its position in Lam Research by 7.4% in the 4th quarter. Legacy Financial Advisors Inc. now owns 7,164 shares of the semiconductor company's stock worth $1,226,000 after buying an additional 494 shares during the last quarter. Finally, Atlantic Union Bankshares Corp boosted its stake in Lam Research by 4.3% in the fourth quarter. Atlantic Union Bankshares Corp now owns 1,928 shares of the semiconductor company's stock worth $330,000 after buying an additional 80 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.